We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $182M
1-Year Est. Return 26.44%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$173M
AUM Growth
-$17.9M
Cap. Flow
-$30.2M
Cap. Flow %
-17.43%
Top 10 Hldgs %
55.08%
Holding
288
New
38
Increased
28
Reduced
38
Closed
40

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$4.21M
2
CERN
Cerner Corp
CERN
+$1.19M
3
UMPQ
Umpqua Holdings Corp
UMPQ
+$656K
4
DHR icon
Danaher
DHR
+$524K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$443K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$8.2M
2
UPS icon
United Parcel Service
UPS
+$6.58M
3
FFIV icon
F5
FFIV
+$6.21M
4
FSLR icon
First Solar
FSLR
+$3.71M
5
ORBK
Orbotech Ltd
ORBK
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 32.47%
2 Technology 20.82%
3 Communication Services 13.22%
4 Financials 11.36%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIAV icon
226
Viavi Solutions
VIAV
$9.02B
$4K ﹤0.01%
400
– –
EFA icon
227
iShares MSCI EAFE ETF
EFA
$79.6B
$3K ﹤0.01%
40
– –
TRST
228
Trustco Bank Corp NY
TRST
$973M
$3K ﹤0.01%
71
– –
VIVO
229
DELISTED
Meridian Bioscience Inc
VIVO
$3K ﹤0.01%
200
– –
MFGP
230
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$3K ﹤0.01%
+90
New +$3.48K
APA icon
231
APA Corp
APA
$14.9B
$2K ﹤0.01%
37
– –
IJT icon
232
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.08B
$2K ﹤0.01%
+20
New +$1.56K
PBW icon
233
Invesco WilderHill Clean Energy ETF
PBW
$387M
$2K ﹤0.01%
100
– –
PER
234
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$2K ﹤0.01%
+650
New +$1.85K
RDC
235
DELISTED
Rowan Companies Plc
RDC
$2K ﹤0.01%
140
– –
HYGS
236
DELISTED
Hydrogenics Corp
HYGS
$2K ﹤0.01%
233
– –
DBO icon
237
Invesco DB Oil Fund
DBO
$258M
$1K ﹤0.01%
100
– –
MOS icon
238
The Mosaic Company
MOS
$7.5B
$1K ﹤0.01%
32
+1
+3% +$22
AIOT
239
PowerFleet Inc
AIOT
$409M
$1K ﹤0.01%
100
– –
ALXN
240
DELISTED
Alexion Pharmaceuticals
ALXN
$1K ﹤0.01%
9
– –
AIG.WS
241
DELISTED
American International Group, Inc.
AIG.WS
$1K ﹤0.01%
+53
New +$1.08K
ILG
242
DELISTED
ILG, Inc Common Stock
ILG
$1K ﹤0.01%
40
– –
BBD icon
243
Banco Bradesco
BBD
$34.4B
$0 ﹤0.01%
16
– –
BHF icon
244
Brighthouse Financial
BHF
$3.05B
$0 ﹤0.01%
+8
New +$456
BML.PRL
245
Bank of America Depository Shares Series 5
BML.PRL
$304M
– –
-330
Closed -$8K
FFIV icon
246
F5
FFIV
$22.3B
– –
-48,909
Closed -$6.21M
GS.PRD icon
247
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
$1.01B
– –
-285
Closed -$7K
IMNN icon
248
Imunon
IMNN
$8.98M
– –
0
– –
MET.PRA icon
249
MetLife Inc Floating Rate Series A
MET.PRA
$509M
– –
-397
Closed -$10K
MS.PRA icon
250
Morgan Stanley Series A Preferred Stock
MS.PRA
$755M
– –
-181
Closed -$4K
7 8 9
10
11

Similar funds

TA
TPG Advisors Northfield, Illinois $182M AUM 18.36% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $182M AUM 22.41% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $182M AUM 21.95% 1-Year Est. Return
SRB
Shotwell Rutter Baer Lansing, Michigan $182M AUM 17.21% 1-Year Est. Return
BFP
Brewster Financial Planning Brooklyn, New York $182M AUM 15.59% 1-Year Est. Return
FNBOH
First National Bank of Hutchinson Hutchinson, Kansas $182M AUM 38.15% 1-Year Est. Return
SIM
Sterling Investment Management Tucson, Arizona $182M AUM 9.75% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Prentiss Smith & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Prentiss Smith & Co held 288 positions worth $173M, down 9.3% from $191M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Prentiss Smith & Co withdrew a net $30.2M in Q3 2017, closing 40 positions and reducing 38 holdings. Its most notable exit was F5, an estimated $6.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Prentiss Smith & Co opened a new position in Regeneron Pharmaceuticals worth $416K.

  • Prentiss Smith & Co's largest Q3 2017 buy was Regeneron Pharmaceuticals: 931 shares worth $416K.
  • Prentiss Smith & Co added most to Oracle in Q3 2017, an estimated $4.21M increase.
  • Prentiss Smith & Co's biggest Q3 2017 reduction was Verizon, cutting an estimated $8.2M.
  • Prentiss Smith & Co fully exited F5 in Q3 2017, selling an estimated $6.21M.
  • Prentiss Smith & Co's ten largest holdings make up 55% of its $173M portfolio in Q3 2017.
  • Prentiss Smith & Co opened 38 new positions and closed 40 in Q3 2017.
  • Prentiss Smith & Co's portfolio value fell 9.3% quarter-over-quarter to $173M.

Based on Prentiss Smith & Co's 13F filing for Q3 2017, filed 23 Oct 2017.